One reason is it is expensive to fund the research and testing and so the companies need to recoup that cost. They cannot in Europe and Canada due to price controls which means people in the US offset the cost. The US is basically subsidizing other Western countries.

^This guy gets it.

Also, in nearly every parliamentary system the state's ability to quickly invalidate patents by an act of parliament gives them even more leverage in the negotiations with drug companies.